Non-reproductive tissues and cells

Similar documents
Non-reproductive tissues and cells

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells

Non-reproductive tissues and cells

Non-reproductive tissues and cells Recommending authority/ association

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Microbiology EQA Product Portfolio

Controls & Calibrators. Disease Quality Controls

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

Programme Groupings. For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group.

STIs- REVISION. Prof A A Hoosen

Directed Semen Donor Eligibility Requirements

HPSC - Weekly Infectious Disease Report

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing

Laboratory diagnostics of blood-borne infections related to blood transfusions and transplantations

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Structure and duties of Blood service

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

HPSC - Weekly Infectious Disease Report

Surveillance Report 2014

Increase in Locally-Acquired Cyclosporiasis Cases in Ontario

HPSC - Weekly Infectious Disease Report

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

Increased Risk Donors. November 1, 2018 BC Kidney Days. Jagbir Gill MD MPH Associate Professor of Medicine UBC

Perform Gram stain only. Select Survey D5, Gram Stain

HPSC - Weekly Infectious Disease Report

Corporate Medical Policy

Egg and Sperm Bank Edinburgh Fertility & Reproductive Endocrine Centre (EFREC) DONOR INFORMATION Screening Tests

MOLECULAR DIAGNOSTIC PANELS and REAGENT KITS for NUCLEIC ACID EXTRACTION and RT-PCR of INFECTIOUS DISEASES and GENOMICS. Sep 2018

Sexually Transmitted Infections. Naluce Manuela Morris, MPH, CHES

Guidance on Performance Evaluation of In-vitro Diagnostic Medical Devices

CONTACTS & ACKNOWLEDGEMENTS

Human tissues and cells annual report 2011

2017 CST-Astellas Canadian Transplant Fellows Symposium. Optimizing use of organs from Increased Risk Donors

COMMUNICABLE DISEASE REPORT

Laboratory Survey Results. Preventing disease, promoting and protecting health

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Storage conditions. roomtemperature or incubator at 36 C. Other: 2-8 C Blood: roomtemperature or incubator at. A.s.a.p. max 24h. A.s.a.p.

Keeping the Blood Supply Safe Current and Future Strategies. Marissa Li, MD

Table of Contents (continued)

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #:

+ Intermittent shedding in urine, + Urinary tract

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Immunohistochemical Confirmation of Infections

For more information about how to cite these materials visit

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

Surveillance Report 2015

In Canada and around the world, the trend is clear: sexually transmitted infections (STIs) are on the rise.

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary

Pathogen Reduction/Inactivation KABB Annual Meeting Elpidio Pena, MD, MA Norton Healthcare Transfusion Services

Emerging Pathogens that Impact the Canadian Blood Supply Alberta Vein to Vein Conference March 18-19, 2016

Telephone: (204) Téléphone: (204) Fax: (204) Télécopieur: (204)

Optimal / Evidence-based Method to Prevent Transmission of Cytomegalovirus (CMV) by Transfusion

Manitoba Monthly Surveillance Unit Report

CORD BLOOD TRANSPLANTATION STUDY CBU EXCLUSION AND QUARANTINE RELEASE FORM

Telephone: Téléphone : Fax: Télécopieur :

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set

Public Health, Infections and Transplantation

"Wanted Poster" Diseases

Laboratory Services and Networks Your priorities?

Surveillance Report 2016

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Sexually Transmi/ed Diseases

School Nursing and Health. Standard Precautions. (aka Universal Precautions)

SEXUALLY TRANSMITED DISEASES SYPHILIS ( LUES ) Dr D. Tenea Department of Dermatology University of Pretoria

Case 1. FDA, Legal, and EBAA Medical Standards Panel. Case 1. Case 1 6/25/2012. Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies

The testing of Donated Blood and Components at NHSBT

Duration: 12 months May to April

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Reporting of Communicable Diseases

Schedule of Accreditation

Version number CAT 2016/01

Management of Needlestick and Mucous Membrane Exposures To Blood/Body Fluids

Orientation Program for Infection Control Professionals

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital

Current Infectious Disease Screening for the Live Organ Donor

LIST OF APPENDICES. Appendix B Ontario Regulation 558/91 Specification of Communicable Diseases

CHAPTER 1: SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS

EQA PROGRAMME CATALOGUE. Version number CAT2019/01

DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I

Coding for Preventive Services A Guide for HIV Providers

Telephone: Téléphone : Fax: Télécopieur :

Communicable Disease Report January 2019

The Communicable Disease Control Regulations

Manitoba Monthly Communicable Disease Report

Increased Risk Donors for Organ Transplantation

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory

Transcription:

Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on national level Tested pathogen VIRAL HIV 1 and HIV 2 Hepatitis B Hepatitis C HTLV-1 Donor test/ technique Legy binding Non-reproductive tissues and cells Recommended on national level Recommending authority/ association Anti-HIV 1 YES N/A Anti-HIV 2 YES N/A HIV 1p24 HIV NAT HBs Ag YES N/A Anti-HBc YES N/A Anti - HBs HBV NAT Anti-HCV YES N/A HCV NAT Technique not specified Anti-HTLV-1 YES N/A Testing must be performed for donors living in, or originating from, high-prevalence areas or with sexual partners originating from those areas or where the donor s parents originate from those areas Circumstances for application Donor profile Tissue/cell type Comments NAT can be done, but not compulsory. NAT can be done, but not compulsory. NAT can be done, but not compulsory. HTLV-2 Chikungunya virus HTLV-1 NAT 1 of 7 1.N-REPRODUCTIVE T&C 30/06/2016

Tested pathogen Donor test/ technique Legy binding Recommended Recommending Circumstances for application Cytomegalovirus Technique not specified YES N/A Testing is mandatory for living donors Dengue Virus Ebola Virus Epstein-Barr virus Hepatitis E Human Parvovirus B19 Herpes simplex virus West Nile Virus PARASITIC Babesiosis Leishmaniasis Malaria Anti-CMV CMV NAT Technique not specified YES N/A Testing is mandatory for living donors Anti-EBV Technique not specified YES N/A Testing is mandatory for living donors Plasmodium sp. Ab Plasmodium sp. Ag Plasmodium sp. Ag - rapid test Plasmodium sp. NAT 2 of 7 1.N-REPRODUCTIVE T&C 30/06/2016

Tested pathogen Donor test/ technique Legy binding Recommended Recommending Circumstances for application Toxoplasmosis Technique not specified YES N/A Testing is mandatory for living donors Anti-Toxoplasma gondii Trypanosomiasis Technique not specified YES N/A Testing is mandatory for living donors Anti-Trypanosoma cruzi BACTERIAL Treponema pidum Technique not specified YES N/A (Syphilis) Anti-T. pidum T. pidum NAT Chlamydia trachomatis Neisseria gonorrhoeae Q-fever FUNGI Transmissible spongiform Other Tests ABO blood group 3 of 7 1.N-REPRODUCTIVE T&C 30/06/2016

Tested pathogen Donor test/ technique Legy binding Recommended Recommending Circumstances for application RhD blood group HLA Genetic, please specify condition RhD typing YES N/A Testing is mandatory for living donors Technique not specified YES N/A Testing is mandatory for living donors HLA Ab HLA Ag HLA gene 4 of 7 1.N-REPRODUCTIVE T&C 30/06/2016

Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on national level Tested pathogen Donor test/ technique Legy binding Recommended Recommending Circumstances for application VIRAL HIV 1 and HIV 2 Hepatitis B Hepatitis C HTLV-1 Reproductive tissues and cells Anti-HIV 1 YES N/A Anti-HIV 2 YES N/A HIV 1p24 HIV NAT HBs Ag YES N/A Anti-HBc YES N/A Anti - HBs HBV NAT Anti-HCV YES N/A HCV NAT Technique not specified Anti-HTLV-1 YES N/A must be performed for donors living in, or originating from, high-prevalence areas or with sexual partners originating from those areas or where the donor s parents originate from those areas HTLV-2 Chikungunya virus Cytomegalovirus Dengue Virus Ebola Virus Epstein-Barr virus Hepatitis E HTLV-1 NAT Technique not specified YES N/A Anti-CMV CMV NAT 5 of 7 2.REPRODUCTIVE T&C 30/06/2016

Tested pathogen Donor test/ technique Legy binding Recommended Recommending Circumstances for application Human Parvovirus B19 Herpes simplex virus West Nile Virus Herpes genitalis PARASITIC Babesiosis Leishmaniasis Malaria Toxoplasmosis Trypanosomiasis BACTERIAL Treponema pidum (Syphilis) Chlamydia trachomatis Technique not specified YES N/A specify technique Technique not specified YES N/A non-partner donors Anti-T. pidum T. pidum NAT Technique not specified YES N/A Neisseria gonorrhoeae C. trachomatis DFA C. trachomatis EIA C. trachomatis NAT YES N/A sperm donors sperm except partners Culture Technique not specified YES N/A Brucellosis Tuberculosis Q-fever Trichomonas vaginalis FUNGI Transmissible spongiform encephalopathies Other Tests N. gonorrhoeae NAT Culture Technique not specified YES N/A specify technique 6 of 7 2.REPRODUCTIVE T&C 30/06/2016

Tested pathogen Donor test/ technique Legy binding Recommended Recommending Circumstances for application ABO blood group RhD blood group Genetic, please specify condition Specify technique YES N/A non-partner donors Genetic is legy binding as national requirement, but the law does not specify technique 7 of 7 2.REPRODUCTIVE T&C 30/06/2016